Pharmaceutical composition
AssigneesUniversity of Strathclyde, The University Court of the University of Glasgow
InventorsBarry Douglas Moore, Marie Claire Parker, Johann Partridge, Jan Vos, Michaela Maria Kreiner, Howard Norman Ernest Stevens, Maria Victoria Flores, Alistair Ross
Life of this patent
Estimating the term…
Abstract
This invention relates to pharmaceutical formulations comprising particles with a substantially non-hygroscopic inner crystalline core and an outer coating comprising at least one bioactive molecule. The invention also relates to methods of forming particles comprising a substantially non-hygroscopic inner crystalline core and an outer coating comprising at least one bioactive molecule.
Claims19
A continuous method of forming particles which comprise microcrystals with a non-hydroscopic inner crystalline core comprising co-precipitant molecules and an outer coating comprising at least one bioactive molecule, comprising the following steps:
- (a) providing a continuous stream of an aqueous solution comprising non-polymeric co-precipitant molecules and bioactive molecules, each co-precipitant molecule substantially having a molecular weight of less than 4 kDa, wherein the aqueous solution is capable of forming a co-precipitate which comprises the co-precipitant and bioactive molecules with a melting point of above about 90° C.;
- (b) rapidly admixing the continuous stream of bioactive molecule/co-precipitant molecule solution with a greater volume of a continuous stream of a substantially water miscible organic solvent such that the co-precipitant and bioactive molecules co-precipitate from solution forming particles which comprise microcrystals with a non-hydroscopic inner crystalline core comprising co-precipitant molecules and an outer coating comprising at least one bioactive molecule, wherein the continuous streams are mixed in a continuous flow process;
- and
- (c) optionally isolating the particles from the organic solvent,
- wherein following mixing with the bioactive molecule the co-precipitant will be at between about 5 and 100% of its aqueous saturation solubility.
Dependencies are inferred from the claim text.